Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in...
Leadership
Frederick G. Vogt Esq., J.D., Ph.D.
Interim CEO, President, General Counsel, Corporate Secretary & Director
Corleen M. Roche
Chief Financial Officer
Igor P. Bilinsky Ph.D.
Chief Operating Officer
Raj K. Puri M.D., Ph.D.
Chief Regulatory Officer
Daniel G. Kirby
Chief Commercial Officer
Sara Pellegrino
Senior Vice President of Investor Relations & Corporate Communications
Tracy Winton
Executive Vice President of Human Resources
Howard B. Johnson M.B.A.
Chief Business Officer
Kevin Smyth
Executive Vice President of Quality
Brian Gastman M.D.
Executive Vice President of Translational Medicine & Research
